413 related articles for article (PubMed ID: 18613851)
1. Factors affecting the uptake of new medicines in secondary care - a literature review.
Chauhan D; Mason A
J Clin Pharm Ther; 2008 Aug; 33(4):339-48. PubMed ID: 18613851
[TBL] [Abstract][Full Text] [Related]
2. New medicines in primary care: a review of influences on general practitioner prescribing.
Mason A
J Clin Pharm Ther; 2008 Feb; 33(1):1-10. PubMed ID: 18211610
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting the uptake of new medicines: a systematic literature review.
Lublóy Á
BMC Health Serv Res; 2014 Oct; 14():469. PubMed ID: 25331607
[TBL] [Abstract][Full Text] [Related]
4. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.
Prosser H; Walley T
Soc Sci Med; 2005 Mar; 60(6):1335-46. PubMed ID: 15626528
[TBL] [Abstract][Full Text] [Related]
5. Prescribing behaviour in general practice: the impact of promoting therapeutically equivalent cheaper medicines.
Roberts SJ; Bateman DN; Smith JM
Br J Gen Pract; 1997 Jan; 47(414):13-8. PubMed ID: 9115786
[TBL] [Abstract][Full Text] [Related]
6. Influencing prescribing in English primary care: the views of primary care organisations.
Mason A; Drummond M; Towse A; Cooke J
J Health Serv Res Policy; 2004 Jul; 9(3):153-8. PubMed ID: 15272973
[TBL] [Abstract][Full Text] [Related]
7. Interactions between physicians and the pharmaceutical industry: what does the literature say?
Lexchin J
CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
[TBL] [Abstract][Full Text] [Related]
8. Perspectives of physicians practicing in low and middle income countries towards generic medicines: a narrative review.
Hassali MA; Wong ZY; Alrasheedy AA; Saleem F; Mohamad Yahaya AH; Aljadhey H
Health Policy; 2014 Sep; 117(3):297-310. PubMed ID: 25129135
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic substitution and therapeutic conservatism as cost-containment strategies in primary care: a study of fundholders and non-fundholders.
Wilson RP; Hatcher J; Barton S; Walley T
Br J Gen Pract; 1999 Jun; 49(443):431-5. PubMed ID: 10562740
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting feasibility and acceptability of a practice-based educational intervention to support evidence-based prescribing: a qualitative study.
Watkins C; Timm A; Gooberman-Hill R; Harvey I; Haines A; Donovan J
Fam Pract; 2004 Dec; 21(6):661-9. PubMed ID: 15528289
[TBL] [Abstract][Full Text] [Related]
11. New drug prescribing by hospital doctors: the nature and meaning of knowledge.
Prosser H; Walley T
Soc Sci Med; 2006 Apr; 62(7):1565-78. PubMed ID: 16199121
[TBL] [Abstract][Full Text] [Related]
12. The impact of pharmacy computerised clinical decision support on prescribing, clinical and patient outcomes: a systematic review of the literature.
Robertson J; Walkom E; Pearson SA; Hains I; Williamsone M; Newby D
Int J Pharm Pract; 2010 Apr; 18(2):69-87. PubMed ID: 20441116
[TBL] [Abstract][Full Text] [Related]
13. Shared care: a qualitative study of GPs' and hospital doctors' views on prescribing specialist medicines.
Horne R; Mailey E; Frost S; Lea R
Br J Gen Pract; 2001 Mar; 51(464):187-93. PubMed ID: 11255899
[TBL] [Abstract][Full Text] [Related]
14. Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee's list of recommended essential medicines (the 'Wise List').
Eriksen J; Ovesjö ML; Vallin M; Juhasz-Haverinen M; Andersén-Karlsson E; Ateva K; Gustafsson LL; Jirlow M; Bastholm-Rahmner P
Eur J Clin Pharmacol; 2018 Jan; 74(1):131-138. PubMed ID: 29063149
[TBL] [Abstract][Full Text] [Related]
15. Prioritizing children's medicines for research: a pharmaco-epidemiological study of antiepileptic drugs.
Ackers R; Murray ML; Besag FM; Wong IC
Br J Clin Pharmacol; 2007 Jun; 63(6):689-97. PubMed ID: 17257162
[TBL] [Abstract][Full Text] [Related]
16. The discomfort caused by patient pressure on the prescribing decisions of hospital prescribers.
Lewis PJ; Tully MP
Res Social Adm Pharm; 2011 Mar; 7(1):4-15. PubMed ID: 21397877
[TBL] [Abstract][Full Text] [Related]
17. Influences on GPs' decision to prescribe new drugs-the importance of who says what.
Prosser H; Almond S; Walley T
Fam Pract; 2003 Feb; 20(1):61-8. PubMed ID: 12509373
[TBL] [Abstract][Full Text] [Related]
18. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
19. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
20. Croatian pharmaceutical sector reform project: rational drug use.
Harvey K; Kalanj K; Stevanović R
Croat Med J; 2004 Oct; 45(5):611-9. PubMed ID: 15495290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
